FIELD: medicine.
SUBSTANCE: solution containing, wt % riboflavin mononucleotide 0.09-0.11, chitosan succinate 9.5-10.5, sodium chloride 0.8-0.9, tris-(hydroxymethyl)-methylamine 0.08-0.12, Nipagin 0.0075-0.0125, Trilon B 0.005-0.01 and purified distilled water is instilled for 15 minutes. That is followed by 6 cycles of the 5-minute ultraviolet light exposure of the cornea of 30 minutes in total at a wavelength of 370 nm and power 3 mW/cm. That is combined with instilling the same solution for three cycles.
EFFECT: higher antiviral action, as well as ensured antimycotic, antimicrobial action and active regeneration of the epithelium in the patients with deep completely inactive herpetic keratitis.
2 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF CORNEAL GRAFT PREPARATION FOR LAYER-BY-LAYER KERATOPLASTY | 2019 |
|
RU2723135C1 |
METHOD OF TREATING EPITHELIAL-ENDOTHELIAL CORNEAL DYSTROPHY | 2019 |
|
RU2703361C1 |
COMBINED METHOD FOR THE TREATMENT OF CORNEAL DISEASES WITH THE USE OF KERATOPLASTY AND CROSS-LINKING | 2017 |
|
RU2676434C1 |
METHOD OF TREATMENT OF KERATECTASIA BY THE METHOD OF PULSE ACCELERATED ULTRAVIOLET CROSSLINKING OF CORNEA | 2017 |
|
RU2682494C1 |
OPHTHALMIC AGENT FOR TRANSEPITHELIAL ULTRAVIOLET CORNEAL COLLAGEN CROSSLINKING | 2014 |
|
RU2560669C1 |
OPHTHALMIC CROSS-LINKING AGENT-2 | 2012 |
|
RU2475248C1 |
OPHTHALMOLOGICAL MEANS FOR ULTRAVIOLET CORNEAL CROSSLINKING | 2016 |
|
RU2646452C1 |
HYPOSMOTIC OPHTHALMIC MEANS FOR ULTRAVIOLET CROSSLINKING OF THIN CORNEAS | 2016 |
|
RU2631604C1 |
CROSS-LINKING OPHTHALMIC AGENT | 2009 |
|
RU2412707C1 |
METHOD FOR PREPARING DONOR MATERIAL FOR KERATOPLASTY | 2022 |
|
RU2806987C1 |
Authors
Dates
2014-10-20—Published
2013-06-24—Filed